This is a sponsored message from a Health Affairs partner.
You are receiving this email because you opted in to Health Affairs Announcements, which include special offers, meeting discounts, job announcements, and news from our trusted partners.
Dear Researchers,
The Leukemia & Lymphoma Society (LLS) is thrilled to announce the release of two Requests for Proposals (RFPs) for its Equity in Access Research Program, which is dedicated to funding health services research.
Our newest RFP is Building Evidence for Effective Strategies to Increase Therapeutic Cancer Clinical Trial Accrual: Promoting Access for Patients from Underrepresented Groups. Awards will be a maximum of $2.5 million each, over 5 years.
We are also reissuing the RFP Understanding How Health Insurance Affects Equity in Access to Care for Patients with and Survivors of Blood Cancer. Awards will be a maximum of $750,000 each, over 3 years.
It is not necessary for applicants to have previously conducted research in blood cancer. The due date for Letters of Intent is September 15, 2023.
You can find the RFPs and more informationat LLS.org/EquityinAccess. Additionally, I encourage you to read about the Program’s most recent cohort of outstanding grantees and their novel research; those details are available on the same webpage.
With many thanks and best regards,
Elisa Weiss, PhD Senior Vice President, Education, Services, & Health Research The Leukemia & Lymphoma Society
About Health Affairs
Health Affairs is the leading peer-reviewed journalat the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online. Late-breaking content is also found through healthaffairs.org, Health Affairs Today, and Health Affairs Sunday Update.
Project HOPE is a global health and humanitarian relief organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.
